Reset filters
  • 31 October 2004

ICAAC: Resistance found in one in seven of treatment-naive US patients

Read the article
  • 31 October 2004

ICAAC: Combination of tenofovir and Trizivir as effective and tolerable as Combivir / efavirenz

Read the article
  • 30 October 2004

ICAAC: Fall in immune cells predicts reaction to abacavir, and high incidence of reaction if abacavir used during primary infection

Read the article
  • 30 October 2004

ICAAC: Treatment breaks riskier if NNRTIs involved

Read the article
  • 30 October 2004

ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy

Read the article
  • 30 October 2004

ICAAC: African-Americans less likely to experience immunologic failure when taking efavirenz

Read the article
  • 28 October 2004

Treatment interruption results in lipid reduction; IL-2 has no effect on lipids

Read the article
  • 28 October 2004

Drug side-effects place treatment scale up at risk, says Ugandan HIV expert

Read the article
  • 28 October 2004

AZT & d4T damage fat cells long before fat loss visible

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.